| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 1 |
| 1 | BEVACIZUMAB | 1 |
| 2 | BUDESONIDE | 1 |
| 3 | CARBOPLATIN | 1 |
| 4 | CETUXIMAB | 1 |
| 5 | CHLORPROMAZINE | 1 |
| 6 | ETOPOSIDE | 1 |
| 7 | GABAPENTIN | 1 |
| 8 | IBUPFROFEN | 1 |
| 9 | IBUPROFEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 1 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 2 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 3 | CHLORPROMAZINE | 1 | 0.0002 |
| 4 | CETUXIMAB | 1 | 0.0000 |
| 5 | APIXABAN | 1 | 0.0000 |
| 6 | ETOPOSIDE | 1 | 0.0000 |
| 7 | VEDOLIZUMAB | 1 | 0.0000 |
| 8 | NIVOLUMAB | 1 | 0.0000 |
| 9 | BEVACIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 1 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Insulin Analog [EPC] | 1 | 0.0000 |
| 8 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 2 | 0.0000 |